Physician profile
Martin E Bacon
NPI 1811961683
$1,590.74
in general payments reported to CMS, 2019-2025
13 companies · $15.81 in 2025
The $15.81 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $200 · 2020: $38.62 · 2021: $176 · 2022: $142 · 2023: $540 · 2024: $479 · 2025: $15.81.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,034.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,034.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $611.48 | 2020-2024 | Repatha |
| Pfizer INC. | $207.11 | 2020-2024 | |
| Medtronic, INC. | $135.53 | 2021-2024 | Cobalt Dr Mri Surescan |
| Impulse Dynamics (USA) INC. | $109.98 | 2023 | Optimizer |
| Boston Scientific Corporation | $102.66 | 2023 | Watchman Access System |
| Edwards Lifesciences Corporation | $100.53 | 2019 | |
| Astellas Pharma US INC | $99.00 | 2019 | |
| Merck Sharp & Dohme LLC | $53.83 | 2024-2025 | Verquvo |
| Baxter Healthcare | $45.45 | 2024 | Hillrom - Cardiac Ambulatory Monitor |
| Philips North America LLC | $34.26 | 2024 | (Ck4) Mcot |
| Novartis Pharmaceuticals Corporation | $34.24 | 2022-2024 | |
| Kiniksa Pharmaceuticals International, Plc | $31.76 | 2024 | Arcalyst |
| Abbott Laboratories | $24.91 | 2023 | Xact |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Martin Bacon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.